Quick Answer
GENTEX CORP reported R&D Expense of $203.26 million for fiscal year 2025.
GENTEX CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $203.26M | +12.0% |
| 2024 | $181.48M | +17.6% |
| 2023 | $154.36M | +15.8% |
| 2022 | $133.31M | +13.2% |
| 2021 | $117.76M | +1.6% |
| 2020 | $115.94M | +1.1% |
| 2019 | $114.69M | +7.0% |
| 2018 | $107.13M | +7.4% |
| 2017 | $99.73M | +5.8% |
| 2016 | $94.24M | +6.6% |
| 2015 | $88.39M | +5.0% |
| 2014 | $84.18M | +10.0% |
| 2013 | $76.50M | -10.0% |
| 2012 | $85.00M | +4.1% |
| 2011 | $81.63M | +27.4% |
| 2010 | $64.10M | +36.0% |
| 2009 | $47.13M | -9.2% |
| 2008 | $51.89M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $52.63M | +9.1% | +2.3% |
| June 30, 2025 | $51.47M | +17.0% | +12.1% |
| March 31, 2025 | $45.92M | +8.9% | -4.8% |
| September 30, 2024 | $48.23M | +20.0% | +9.6% |
| June 30, 2024 | $44.00M | +15.9% | +4.3% |
| March 31, 2024 | $42.18M | +21.7% | +4.9% |
| September 30, 2023 | $40.20M | +19.8% | +5.9% |
| June 30, 2023 | $37.97M | +15.6% | +9.6% |
- GENTEX CORP showed an increase of +12.0% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2025 period, GENTEX CORP’s r&d expense has grown by 291.7% (from $51.89 million to $203.26 million).
- The most recent figure is from GENTEX CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: